(Q37618340)

21 August 2017

1 reference

title

The development of albendazole for lymphatic filariasis (English)

1 reference

21 August 2017

0 references

J Horton

1

1 reference

21 August 2017

publication date

1 October 2009

1 reference

Annals of Tropical Medicine and Parasitology

21 August 2017

published in

1 reference

21 August 2017

volume

103 Suppl 1

1 reference

21 August 2017

page(s)

S33-40

1 reference

Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Single-dose treatment of wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: Evaluation of the potential for control at 12 months after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Decrease in Mansonella perstans microfilaraemia after albendazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

The role of albendazole in programmes to eliminate lymphatic filariasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F000349809X12502035776595

10.1179/000349809X12502035776595

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference